- Home
- GDO vs ORMP Comparison
GDO vs ORMP Comparison
Compare GDO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GDO | ORMP |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.6M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GDO | ORMP |
|---|---|---|
| Price | $11.80 | $3.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.4K | ★ 182.4K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 9.81% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.21 | $1.82 |
| 52 Week High | $13.04 | $3.20 |
Technical Indicators
Market Signals| Indicator | GDO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 70.03 |
| Support Level | $11.63 | $2.83 |
| Resistance Level | $11.93 | $3.03 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 59.38 | 84.48 |
Price Performance
Historical ComparisonAbout GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.